DSDeidre Anne De Silva

Deidre Anne De Silva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Deidre Anne De Silva has a total of 457 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • International modified Delphi consensus on assessment and management of covert brain infarction

    by Bruno Kusznir Vitturi, Terence J Quinn, Götz Thomalla, Frank J Wolters, Frank-Erik de Leeuw, Silja Räty, Aristeidis H Katsanos, Deidre Anne De Silva, Gisele Sampaio Silva, Brett Cucchiara, et al.

    Background: Covert brain infarction is a frequent incidental neuroradiological finding increasingly recognized as clinically relevant due to its association with stroke, cognitive decline, and other adverse outcomes. However, substantial uncertainty remains regarding its optimal assessment and management, and existing guidelines provide limited and heterogeneous recommendations. We aimed to develop an international expert consensus on the evaluation and management of covert brain infarction using a modified Delphi methodology. Methods: A modified Delphi process was conducted with an international, multidisciplinary panel of 21 experts from 15 countries, including neurologists, neuroradiologists, neuroepidemiologists, and geriatricians. An initial questionnaire was developed from a structured literature review and identified clinical practice gaps. The survey included 91 statements across four domains: (1) prognosis, etiology, and screening; (2) neuroimaging-based management and follow-up; (3) cardiac evaluation; and (4) pharmacological management. Two iterative rounds were conducted, with anonymized responses, controlled feedback, and structured discussion. A 5-point Likert-type scale was used. Consensus was defined a priori as ⩾ 70% agreement. Results: Consensus was reached on 33/91 statements (36.3%), moderate agreement on 43/91 (47.2%), and no consensus on 15/91 (16.5%). The panel agreed that covert brain infarction is associated with increased risk of ischemic stroke, cognitive impairment, and dementia, and that risk is higher with multiple lesions. Consensus supported targeted clinical evaluation, including a cardiac workup with transthoracic echocardiography in all patients and vascular imaging in selected cases. Routine population screening and systematic postprocedural imaging were not supported. Regarding management, consensus favored optimizing vascular risk factors, particularly strict blood pressure control in hypertensive patients. There was no consensus on routine antiplatelet therapy for incidental covert brain infarction, and anticoagulation was generally not supported in the absence of cardioembolic indications. Lipid-lowering therapy showed limited consensus regarding specific benefits for covert brain infarction–related outcomes. Conclusion: This Delphi consensus highlights substantial variability in the perceived management of covert brain infarction and identifies areas of convergence, particularly in risk stratification and control of vascular risk factors. Key uncertainties remain regarding antithrombotic strategies, lipid-lowering therapy, and long-term surveillance. These results provide a pragmatic, expert-based framework to support clinical decision-making and further highlight the need for prospective studies and randomized trials in this rapidly evolving field.

  • Rule-based automation of carpal tunnel syndrome interpretation and reporting in nerve conduction studies: a proof-of-concept study

    by Wai Dic Foong, Shridevika Maharajan, Daryl Yin Keong Lo, You Jiang Tan, Jen Hong Tan, Deidre Anne De Silva

  • Open Access

    Automated Multisource Electronic Frailty Index in Acute Ischemic Stroke: Development and Clinical Utility

    by Lin Zhi Zheng Shawn, Foo Wei Ting, Ng Yee Sien, Chang Hui Meng, Laura Tay, Deidre Anne De Silva

    Background: Frailty is common in acute ischemic stroke (AIS) and predicts poor outcomes, but is not routinely captured in acute stroke care. Manual frailty tools are difficult to apply consistently in busy inpatient settings, while existing electronic frailty indices (eFIs) often rely on limited data modalities. We developed a scalable pre-stroke electronic frailty index (eFI) using multisource electronic medical record (EMR) data and evaluated its clinical utility. Methods: We conducted a retrospective cohort study of AIS admissions to Singapore General Hospital from July 1, 2024, to January 31, 2025. A fully automated pipeline derived an eFI from EMR data over a 3-year lookback period, incorporating ICD-10 codes, vital signs, anthropometry, laboratory results, medications, and free-text documentation processed using artificial intelligence–augmented extraction of predefined, clinically interpretable deficits. Candidate variables were screened using a validated 10-step frailty index framework and refined by multidisciplinary expert consensus. Results: Among 501 AIS cases, the pipeline generated 75 candidate variables and a final 33-variable eFI, with scores derived for 492 cases (98.2%). Frail patients had greater premorbid disability, higher stroke severity, longer hospitalization, greater rehabilitation use, worse discharge disability, higher 30-day readmission, and higher cumulative post-discharge mortality. In multivariable analyses adjusted for age, sex, NIHSS, premorbid mRS, and reperfusion therapy, each 0.1-unit increase in eFI was associated with mortality beyond 90 days after discharge (adjusted HR, 1.47; 95% CI, 1.19–1.81), 30-day readmission (adjusted OR, 1.91; 95% CI, 1.43–2.59), longer hospital stay (β, 2.8 days; 95% CI, 1.4–4.2), and discharge to inpatient rehabilitation rather than home (adjusted RRR, 1.66; 95% CI, 1.27–2.16). Conclusions: In a well-documented acute stroke service supported by comprehensive longitudinal EMR data, automated multisource eFI derivation was feasible and clinically informative in AIS, capturing baseline vulnerability beyond conventional stroke measures and supporting frailty-informed risk stratification and discharge planning.

  • Open Access

    Multi-mOdal Training program to promote physical actIVity After sTrokE (MOTIVATE): Protocol for a hybrid type 1 effectiveness-implementation randomised controlled trial

    by Shamala Thilarajah, Yong Hao Pua, Deidre De Silva, Julian Thumboo, Lian Leng Low, Jenna Hollis, Marie-Louise Bird, Ross Clark, Juliana Wang, Pevenpreet Kaur, et al.

    Background: Physical activity (PA) is a key modifiable behaviour for secondary prevention and recovery after stroke, yet effective and scalable PA interventions remain limited. MOTIVATE (Multi-mOdal Training program to promote physical actIVity After sTrokE) is a theory-informed, co-designed behaviour change intervention developed with stroke survivors, caregivers, and healthcare professionals to address these gaps.Aim: To determine whether MOTIVATE increases device-measured moderate-to-vigorous physical activity (MVPA) at 3 and 6 months among community-dwelling stroke survivors in Singapore, and to evaluate intervention fidelity, mechanisms of impact, and contextual factors relevant to future implementation and scale-up.Methods: MOTIVATE is a hybrid type 1 effectiveness–implementation, phase III randomized controlled trial with concealed allocation, assessor-blinded outcome measurement, and intention-to-treat analysis. Adults aged ≥21 years, ≥6 months post-stroke, living at home, and ambulant with or without an aid are eligible. Participants are randomized to MOTIVATE or education-alone care. Outcomes are assessed at baseline, 3 months, and 6 months, alongside process and economic evaluations. Recruitment of 120 participants provides 80% power to detect a 10-minute/day difference in MVPA, allowing for 20% attrition.Study outcomes: The primary outcome is average daily minutes of MVPA measured using Fitbit Inspire HR. Secondary outcomes include additional PA measures, physical function, participation, self-efficacy, fatigue, mood, sleep, quality of life, and health service utilisation. Outcomes will be analysed using Bayesian mixed-effects models.Discussion: MOTIVATE will provide new evidence on the effectiveness, implementation and cost-effectiveness of a co-designed, personalised behaviour change intervention to increase PA after stroke, supporting future scale-up in routine care.

  • Open Access

    The importance of advocacy in advancing stroke care: The global stroke action coalition

    by Michelle LA Nelson, Maria Grupper, Hb van der Worp, Nicoletta Brunelli, Narayanaswamy Venketasubramanian, Fawaz Al-Mufti, Kaiz Asif, Ruth Asperen, Angelique Balguid, Sarah Belson, et al.

    Stroke represents one of the most significant global health challenges of the 21st century, with 11.9 million people experiencing stroke annually and a disproportionate burden falling on low- and middle-income countries, where 87% of stroke deaths and 89% of disability occur. Despite stroke being highly preventable—with 84% of the burden attributable to modifiable risk factors—and the availability of treatments that have proven to reduce the rate of death or disability, including stroke units, thrombolysis, and thrombectomy, these interventions remain inaccessible to most of the world’s population. Advocacy—systematic efforts to influence policy, practice, and resource allocation through evidence-based engagement with decision-makers—has achieved notable successes such as establishing stroke units globally. However, individual advocacy efforts face structural limitations in addressing global stroke challenges. The Global Stroke Action Coalition (GSAC) was formed in 2024 as a coordinated, multi-sectoral initiative convened by the World Stroke Organization, uniting scientific, civil societies, and industry partners to transcend these limitations. The Coalition leverages established infrastructure and expertise to create a unified advocacy force capable of commanding attention from global health leaders. Centered around five strategic priorities—integrating stroke into national non-communicable disease (NCD) strategies, developing National Stroke Action Plans, securing funding commitments, implementing monitoring systems, and including survivors in policy development—the Coalition successfully utilized the 2025 UN High-Level Meeting on Non-Communicable Diseases to further elevate the position of stroke on the global agenda. Key achievements include securing ministerial commitments from 10 countries and launching the “Every Minute Counts” campaign. The Coalition’s coordinated approach demonstrates that systematic, evidence-based advocacy can transform stroke care delivery globally, providing a framework for sustained collaboration across sectors and regions essential for meeting Sustainable Development Goal targets and reducing the devastating burden of stroke worldwide.


  • Why Genetics Can’t Be Ignored in Secondary Stroke Prevention: The CYP2C19 Challenge in Asia

    by Anushika Raheja, Deidre Anne De Silva, Kaavya Narasimhalu

    Stroke is a leading cause of death and disability globally, with Asia disproportionately affected. A critical barrier to effective secondary prevention is the high prevalence of CYP2C19 loss-of-function alleles, present in almost 75% of South and East Asians, which reduce clopidogrel efficacy. Evidence from trials, including CHANCE-2 (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events), shows that genotype-guided alternatives, including ticagrelor and cilostazol, substantially lower recurrent stroke risk in loss-of-function carriers. Yet, clinical adoption remains limited by insufficient genetic testing infrastructure, cost, guideline gaps, and clinician training. Despite these challenges, genotype-guided therapy is both feasible and cost-effective, with the potential to reduce recurrent strokes, disability, and healthcare burden. Urgent action is required to implement precision antiplatelet strategies, update guidelines, and ensure equitable access, making pharmacogenomics a central component of stroke care in Asia.


  • Sex Differences in Prehospital Stroke Medicine (SESAME): A Systematic Review and Meta-Analysis

    by Brittany Wells, Ahmed Nasreldein, Karianne Larsen, Frederike van Wijck, Cheryl Carcel, Hanne Christensen, Maren Ranhoff Hov, Valeria Caso, Mark Woodward, Deidre Anne De Silva, et al.

    BACKGROUND: Several studies have evaluated sex discrepancies in the prehospital management of patients with acute stroke. This systematic review and meta-analysis aims to summarize reported knowledge about sex differences in dispatch center and emergency medical service management. It proposes a roadmap of questions and the next necessary steps to ensure equitable prehospital stroke care. METHODS: We conducted a systematic review and meta-analysis, using a random-effects model with inverse weighting. PubMed, CINAHL, EMBASE, and EMCARE were searched for studies investigating sex differences in the prehospital management of patients with suspected and acute stroke. The main outcome was the relative risk (RR) for receiving a correct prehospital stroke diagnosis. Additional outcomes are related to prehospital management and time metrics. RESULTS: Sixteen studies were included, comprising 571 024 male patients and 622 764 female patients. No relevant risk of bias was detected. Female patients were less often correctly identified as stroke suspects than male patients (RR, 0.92 [95% CI, 0.89–0.96]; I 2 =73%). No differences were observed in the number receiving a dispatch code stroke (RR, 0.95 [95% CI, 0.88–1.02]; I 2 =96%), prenotification to hospital by emergency medical service (RR, 0.98 [95% CI, 0.96–1.00]; I 2 =92%), or conveyance to a stroke center (RR, 0.99 [95% CI, 0.79–1.24]; I 2 =82%). There was no difference in mean time from emergency call to hospital door (mean difference, 1.12 [95% CI, −0.64 to 2.89] minutes; I 2 =96%). No conclusion could be drawn for outcomes of on-site clinical management, emergency medical service-to-hospital team interaction, and most of the time metrics due to a lack of data. CONCLUSIONS: This analysis indicates sex differences in the prehospital recognition of acute stroke. However, significant heterogeneity and a lack of data for most steps of prehospital care also highlight the urgent need for high-quality studies to systematically investigate prehospital management disparity between female and male patients with suspected acute stroke. REGISTRATION: URL: https://crd.york.ac.uk/PROSPERO/ ; Unique identifier: CRD42023442997.


  • Non-Traditional Chinese and non-Ayurvedic complementary and alternative medicine in Southeast Asian post-stroke care: A systematic review

    by Trishan Manav Sri Ram, Jayanth Jayabaskaran, Ryan Seng Hong Wong, Deidre Anne De Silva

    Background and Purpose: Stroke has a particularly high incidence and mortality in the Association of Southeast Asian Nations (ASEAN) region. Complementary and alternative medicine (CAM) usage is widespread in this region, including Traditional Chinese Medicine (TCM) and Ayurvedic medicine, but also other forms of traditional medicine. This study aims to systematically review the prevalence, type and effectiveness of non-TCM non-Ayurvedic CAM in post-stroke patients in the ASEAN region. Methods: PubMed, Embase and Scopus databases were searched from inception to 27 July 2024. Studies with patients from the ASEAN region who were diagnosed with stroke and used any CAM that was not TCM or Ayurvedic medicine were included. Two independent authors screened through relevant articles, extracted data and assessed risk of bias. Results: Sixteen studies from four countries were included. The use of massages, herbs, spiritual and energy healing methods were widely adopted for post-stroke patients in the ASEAN region. Evidence for CAM improving neurological and physical stroke outcomes were limited. Despite this, studies have been largely unanimous in reporting improved psychological and quality of life outcomes following CAM use. Conclusions: There is a severe paucity of published literature on non-TCM and non-Ayurvedic CAM use in stroke patients in the ASEAN region despite likely widespread use. There is some evidence of potential benefit but these are limited to subjective patient-reported outcomes. More research is needed to understand its impact and how best to complement conventional stroke care without compromising outcomes.

  • Open Access

    Why patients say no: Patient barriers to epilepsy surgery among patients with drug‐resistant epilepsy in Singapore

    by Zhibin Tan, Meenatchii Shanmugham, Sangeetha Adiyapatham, Zhi En Chan, Zhi Yi Chan, Hua Chan Ling, Jia Yi Shen, Tushar Gosavi, Deidre Anne De Silva, Shih Hui Lim

    Objective: Epilepsy surgery is globally underutilized due to disease‐, system‐, and patient‐related barriers. These barriers are suboptimally understood in Asia. Patient‐related barriers are of particular interest because they are culture‐specific and may present a significant obstacle regardless of resource availability. This study aims to identify patient‐related barriers in Singapore, an ethnically heterogeneous Asian country. Methods: We conducted a cross‐sectional survey of focal drug‐resistant epilepsy (DRE) patients attending the neurology specialist outpatient clinic of a major tertiary hospital in Singapore. The survey contained 28 items assessing patient perceptions of epilepsy and its treatment, and 7 items on the patient's socioeconomic status. It was adapted with permission from a previous Canadian study. Results: A total of 66 patients completed the survey. Most patients (74.2%) were aware of surgery as an option for the treatment of epilepsy, and patients with university degrees were more likely to be aware ( p = 0.007). Most (69.7%) viewed surgery as a “last resort,” and 83.3% overestimated the risks of surgery. Even when hypothetically offered guarantees of surgical success, only 57.6% of patients responded favorably to surgery, with those acknowledging their seizures as disabling being more likely to respond favorably ( p = 0.027). Financial considerations did not significantly influence reactions to hypothetically successful surgery ( p = 1.000). Significance: There are major patient‐related barriers to epilepsy surgery among DRE patients in Singapore, contributed by an overestimation of surgical risks and an indifference to seizure‐related disability in some patients. Based on our findings, financial subsidies alone may not suffice in addressing patient‐related barriers; accompanying patient education efforts may be important. Plain Language Summary: A survey of patients with refractory epilepsy in Singapore revealed that patients are relatively averse to undergoing pre‐surgical evaluation and surgical treatment for epilepsy, despite scientific evidence of effectiveness. Some of the major barriers include patients overestimating the risks of epilepsy surgery and perceiving seizures to be non‐disabling. Our findings suggest that financial subsidies for surgery alone may not overcome patients' aversion to surgery, and that patient education is also required.